DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately four "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

06 Nov 2017

Orphazyme publishes offering circular and the indicative offer price range for its IPO

Orphazyme, a Danish biotech company with a late stage orphan drug pipeline, today published an offering circular and the indicative price range in connection with its intended initial public offering (“IPO” or the “Offering”) and subsequent admission to trading and official listing of its shares on Nasdaq Copenhagen.

The indicative offer price range is DKK 64 to DKK 80 per share of nominal value DKK 1 each, and commitments to subscribe for a number of shares in the Offering, subject to certain conditions, have already been expressed by SEB, Vækstfonden, BankInvest on behalf of certain clients, Handelsbanken and Spar Nord – corresponding to DKK 230 million.

  • Orphazyme offering circular announcement

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2017 Danskbiotek. All rights reserved.